Trials / Not Yet Recruiting
Not Yet RecruitingNCT06024525
Verify Effectiveness and Safety of Paclitaxel-Coated Coronary Balloon Catheters Swide®
Prospective, Multi-center Non-inferiority and Randomized Controlled Clinical Study to Verify Effectiveness and Safety of Paclitaxel-Coated Coronary Balloon Catheters Swide®
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 236 (estimated)
- Sponsor
- Shanghai Shenqi Medical Technology Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the safety and efficacy of the Paclitaxel-Coated Coronary Balloon Catheters Swide® (3µg/mm2 balloon surface area) in the treatment of Chinese patients with native coronary heart disease and small vessel lesions(reference diameters from 2.0mm to 2.75 mm) in comparison with Paclitaxel-Releasing Coronary Balloon Catheter SeQuent® please Neo
Detailed description
This study conducted a prospective, multi-center, randomized controlled, non-inferiority clinical trial to compare the safety and efficacy of the Shenqi Medical paclitaxel-coated coronary balloon catheter and the paclitaxel-eluting coronary balloon catheter (SeQuent® please Neo) in the treatment of coronary artery small vascular disease. * A total of 236 participants are planned to be recruited, and they will be allocated into the experimental group and the control group in a 1:1 ratio. * All participants will undergo clinical follow-up at 1 month, 6 months, 9 months, 1 year, and 2 years after receiving the drug-eluting balloon angioplasty procedure. * Angiographic re-evaluation will be conducted for all participants at 9 months after the procedure. The primary study endpoint will be the in-segment diameter stenosis in target lesion(%) at 9 months postoperatively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Paclitaxel-Coated Coronary Balloon Catheters | to Verify Effectiveness and Safety of Paclitaxel-Coated Coronary Balloon Catheters in SVD patients |
| DEVICE | Paclitaxel-Releasing Coronary Balloon Catheters | to Verify Effectiveness and Safety of Paclitaxel-Coated Coronary Balloon Catheters in SVD patients |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2025-06-01
- Completion
- 2026-06-01
- First posted
- 2023-09-06
- Last updated
- 2023-09-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06024525. Inclusion in this directory is not an endorsement.